Sunday, May 28, 2023 | Back issues
Courthouse News Service Courthouse News Service

Investing in Big Pharma

Shares dropped more than 50 percent to $6.39 after Amicus Therapeutics corrected a press release that had misrepresented the progress of its new Fabry disease treatment, migalastat, a class of investors claims.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.